Nevanac Europska Unija - hrvatski - EMA (European Medicines Agency)

nevanac

novartis europharm limited - nepafenaka - pain, postoperative; ophthalmologic surgical procedures - ophthalmologicals - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Yellox Europska Unija - hrvatski - EMA (European Medicines Agency)

yellox

bausch + lomb ireland limited - bromfenak natrij seskvihidrat - pain, postoperative; ophthalmologic surgical procedures - ophthalmologicals - liječenje postoperativne očne upale nakon ekstrakcije katarakta kod odraslih osoba.

Naclof 1 mg/ml kapi za oko, otopina Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

naclof 1 mg/ml kapi za oko, otopina

novartis hrvatska d.o.o., radnička cesta 37b, zagreb, hrvatska - diklofenaknatrij - kapi za oko, otopina - urbroj: 1 ml otopine sadrži 1 mg diklofenaknatrija

Prepandrix Europska Unija - hrvatski - EMA (European Medicines Agency)

prepandrix

glaxosmithkline biologicals s.a. - a / indonesia / 05/2005 (h5n1) kao soj koji se koristio (pr8-ibcdc-rg2) - influenza, human; immunization; disease outbreaks - cjepiva - aktivna imunizacija protiv h5n1 podtipa virusa gripe a. ovaj prikaz se temelji na imunogenosti podataka od zdravih ispitanika u dobi od 18 i dalje godina nakon uvođenja dvije doze cjepiva, kuhani s podtipa h5n1 sojeva . prepandrix mora se koristiti u skladu sa službenim vodstvom.

Jyseleca Europska Unija - hrvatski - EMA (European Medicines Agency)

jyseleca

gilead sciences ireland uc, galapagos nv - filgotinib maleate - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.